glp-1 obesity drug news today october 23 2025 oct GLP-1 Drugs: 2025 Pulse Survey (U.S.) GLP-1 Pharmacy Pricing Update (Dec

[DOI] [PubMed] [Google Scholar] 299.Mandoe M.J., Hansen K.B., Hartmann B., Rehfeld J.F., Holst J.J., Hansen H.S

Specifically, the ELIXA (lixisenatide) trial studied patients with T2DM who had recent acute coronary syndrome and found that the addition of lixisenatide to conventional therapy did not result in a significant difference in cardiovascular endpoints relative to placebo (Table 1) [56]

518,519,520,521 Hepatocellular carcinoma (HCC) Initially developed for treating diabetes, GLP-1RAs have shown potential in treating NASH, which is closely related to HCC

A review article in 2021 discussed the utility of GLP-1RA for the treatment of IIH, with a particular focus on weight management (5)